Inspirion Delivery Sciences
233 Mount Airy Road
Suite 100
Basking Ridge
New Jersey
07920
United States
Tel: 732-907-0438
Fax: 908-758-1201
Website: http://inspiriondt.com/
Email: info@inspirionrx.com
About Inspirion Delivery Sciences
Inspirion Delivery Sciences (Inspirion) is a specialty pharmaceutical company focused on developing and commercializing unique and innovative products that provide options to patients and physicians to help address the growing societal problem of prescription drug abuse. Our products are designed to provide abuse deterrent features and benefits based on our novel, patent-protected SentyBond™ technology platform.Our management team has significant experiencing in formulating, developing, and commercializing differentiated pharmaceutical products.
YEAR FOUNDED:
2014
LEADERSHIP:
CEO: Stefan Aigner, MD, CFA
CFO: Kip Martin
CSO: Manish Shah, MS, RPh
Chief Commercial Officer: Michael Innaurato
President: Ray DiFalco
CAREER:
Please click here for Inspirion Delivery Sciences' job opportunities.
3 articles about Inspirion Delivery Sciences
-
Daiichi Sankyo And Inspirion Delivery Sciences Announce Plans For Commercialization Of RoxyBond (Oxycodone Hydrochloride) Tablets CII In The U.S.
5/30/2017
-
Inspirion Delivery Sciences Receives FDA Approval For RoxyBond (Oxycodone Hydrochloride) Tablets CII, The First And Only Immediate Release Opioid Analgesic With Abuse-Deterrent Label Claims
4/26/2017
-
Daiichi Sankyo And Inspirion Delivery Sciences Announce U.S. Licensing Agreement For MorphaBond Formulated With SentryBond Abuse-Deterrent Technology
10/25/2016